Market Cap (In SEK)
81.1 Million
Revenue (In SEK)
1.46 Million
Net Income (In SEK)
-9.93 Million
Avg. Volume
26.95 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0-9.2
- PE
- -6.8
- EPS
- -0.44
- Beta Value
- 0.554
- ISIN
- SE0015988274
- CUSIP
- -
- CIK
- -
- Shares
- 27126600.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Gustav Hanghoj Gram
- Employee Count
- -
- Website
- https://pilapharma.com
- Ipo Date
- 2021-07-15
- Details
- PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
More Stocks
-
SHUBHAMShubham Polyspin Limited
SHUBHAM
-
MPL
-
TTFL
-
NATHINDNATH INDUSTRIES LIMITED
NATHIND
-
002866
-
THCH
-
2034YC Inox Co.,Ltd
2034
-
EVSVEnviro-Serv, Inc.
EVSV